Pilot Study of Oligonol Supplementation to Promote Cardiovascular Health

Inclusion Criteria: * Age 18-50 yrs. * Healthy, not taking prescription medications * Subject is willing and able to comply with the study protocols. * Subject is willing to consume the Oligonol extract drink or placebo once a week for each of three weeks. Exclusion Criteria: * Physical signs of health impairment. * Abnormal clinical laboratory (CBC, chemistry, liver, etc.) values if determined to be clinically significant by Dr. Eric Gershwin * Inflammatory disorders (e.g. rheumatoid arthritis) * Malabsorption * Treatment with corticosteroids, hypolipidemic and anti-inflammatory drugs * Renal or Liver disease * Heart Disease, which includes cardiovascular events and stroke * Cushing's syndrome * History of psychiatric disorders i.e. schizophrenia or bi-polar or depression treated with antidepressants within the last 1 year. * Anti-anxiety medications * Routine use of prescription drugs or over-the counter medications, which may potentially modulate the outcome of this study; including antibiotics, aspirin and aspirin-containing formulations, COX-2 inhibitors, antihistamines, corticosteroids, ACE-inhibitors, and beta-blockers, erectile dysfunction drugs. * Asthma (can be worsened by mild to moderate food allergies). * Indications of substance or alcohol abuse within the last 3 years * Undergoing nicotine cessation therapy * Multi-Vitamin and mineral use other than a One-A-Day type formula * Current, consistent use of herbal or plant-based supplements; omega-3 fatty acids, and fish or unwilling to discontinue use while participating in the study. * Alcohol consumption \> 1 oz/day (2 beers/day or 2 glasses of wine/ day, 1 drink of hard liquor/day) * Chronic high-intensity exercise * Smoking